Board Meeting27 Apr 2026, 09:01 am
Cohance Lifesciences: Vivek Sharma Resigns, Umang Vohra Appointed
AI Summary
Cohance Lifesciences Ltd's board meeting on April 27, 2026, addressed key management changes and approved an ESOP. Mr. Vivek Sharma resigned as Executive Chairman and Director, effective April 30, 2026, but will remain as a Special Advisor for nine months. Mr. Umang Vohra was appointed as Additional Director, designated as Chairman, and Group Chief Executive Officer, effective May 1, 2026, for five years, subject to shareholder approval. The board also approved the Cohance Lifesciences Limited – Employee Stock Option Plan, 2026, pending shareholder approval.
Key Highlights
- Vivek Sharma resigns as Executive Chairman and Director, effective April 30, 2026.
- Umang Vohra appointed as Additional Director, Chairman, and Group CEO, effective May 1, 2026.
- Board approves Cohance Lifesciences Limited – Employee Stock Option Plan, 2026.
- Shareholder approval sought for appointment of Umang Vohra and ESOP plan.